
Chimerix Balance Sheet 2024-2010 | CMRX
Brief overview of Chimerix's balance sheet structure
This overview follows the five latest available annual observations between 2020 and 2024.
Assets reached $146 million, compared with $84.7 million at the beginning. Growth of +72.3% and CAGR near 14.6% show active expansion.
Liability growth of +114.4% exceeded asset growth of +72.3%, increasing reliance on outside funding.
Internal capital represents 83.3% of the balance sheet, previously 86.6%. This is a strong capital position.
Cash exceeds interest-bearing debt, producing net debt of -$29.9 million. The balance sheet therefore carries a net cash position.
The cash reserve occupies 21.3% of the balance sheet, previously 55.5%. It is one marker of short-term resilience.
Retained earnings are negative at -$883.9 million. This reduces the formal capital cushion, although large shareholder returns may have contributed.
What the balance sheet shows
Chimerix's financial position is more positive than negative: the funding mix is workable, although the cushion is not unlimited.
Annual Balance Sheet Chimerix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-29.9 M | -25.8 M | -23.4 M | -13 M | - | -16.7 M | -81 M | -18.3 M | -51 M | -20.6 M | -124 M | -100 M | -5.29 M | -11 M | - |
Long Term Debt |
458 K | 1.18 M | 1.82 M | 2.39 M | - | - | - | - | - | - | - | 4.29 M | 9.87 M | 2.44 M | - |
Long Term Debt Current |
719 K | 642 K | 573 K | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | 196 K | 144 K | 224 K | 441 K | 354 K | 175 K | 4.64 M | 10.2 M | 8.93 M | - |
Total Current Liabilities |
23.9 M | 18.4 M | 20.4 M | 29.9 M | 8.53 M | 9.23 M | 13 M | 13.2 M | 10.1 M | 20.2 M | 17.1 M | 10.2 M | - | - | - |
Total Liabilities |
24.3 M | 19.7 M | 22.5 M | 32.3 M | 11.3 M | 9.42 M | 13.1 M | 13.4 M | 10.5 M | 20.5 M | 17.2 M | 14.8 M | 17.8 M | 15.7 M | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | 1.54 M | - | - | - | - |
Retained Earnings |
-884 M | -796 M | -713 M | -886 M | -712 M | -669 M | -556 M | -487 M | -416 M | -339 M | -222 M | -163 M | -102 M | -93.7 M | - |
Total Assets |
146 M | 213 M | 279 M | 101 M | 84.7 M | 119 M | 191 M | 235 M | 287 M | 356 M | 292 M | 113 M | 32 M | 25.4 M | - |
Cash and Cash Equivalents |
31 M | 27.7 M | 25.8 M | 15.4 M | 47 M | 16.9 M | 81.1 M | 18.5 M | 51.5 M | 20.6 M | 128 M | 110 M | 19.9 M | 13.6 M | 3.31 M |
Book Value |
122 M | 193 M | 257 M | 68.3 M | 73.4 M | 110 M | 178 M | 222 M | 276 M | 335 M | 275 M | 98.5 M | 14.2 M | 9.69 M | - |
Total Shareholders Equity |
122 M | 193 M | 257 M | 68.3 M | 73.4 M | 110 M | 178 M | 222 M | 276 M | 335 M | 275 M | 98.5 M | -101 M | -93.7 M | -59.6 M |
All numbers in USD currency
Quarterly Balance Sheet Chimerix
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
644 K | 827 K | 1 M | 1.18 M | 1.34 M | 1.51 M | 1.67 M | 1.82 M | 1.97 M | 2.11 M | 2.26 M | 2.39 M | 2.52 M | 2.65 M | 2.75 M | 2.81 M | 2.92 M | 2.3 M | 48 K | 196 K | 352 K | 519 K | 782 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
22.9 M | 22.9 M | 19.9 M | 19.7 M | 17 M | 17 M | 18.2 M | 22.5 M | 19.9 M | 25.6 M | 17.7 M | 32.3 M | 28.8 M | 27.6 M | 25 M | 11.3 M | 10.3 M | 8.54 M | 6.73 M | 9.42 M | 15.8 M | 14.3 M | 13.7 M | 13.1 M | 9.55 M | 9.59 M | 9.21 M | 13.4 M | 9.19 M | 8.01 M | 9.03 M | 10.5 M | 9.9 M | 10.8 M | 10.5 M | 20.5 M | 21.3 M | 22.2 M | 16.6 M | 17.2 M | 17.4 M | 14 M | 12.5 M | 14.8 M | 15 M | 15.5 M | 28.5 M | 25.3 M | 25.3 M | 25.3 M | 25.3 M | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | 4.85 M | - | 175 K | - | - | - | - | - | - | - | - | 5.08 M | - | - | 113 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-861 M | -838 M | -817 M | -796 M | -777 M | -753 M | -735 M | -713 M | -692 M | -934 M | -910 M | -886 M | -846 M | -828 M | -810 M | -712 M | -701 M | -689 M | -679 M | -669 M | -665 M | -592 M | -574 M | -556 M | -541 M | -525 M | -507 M | -487 M | -468 M | -450 M | -434 M | -416 M | -401 M | -384 M | -366 M | -339 M | -302 M | -269 M | -244 M | -222 M | -202 M | -185 M | -173 M | -163 M | -155 M | -148 M | -135 M | -101 M | -101 M | -101 M | -101 M | - | - | - | - |
Total Assets |
159 M | 179 M | 194 M | 213 M | 225 M | 241 M | 259 M | 279 M | 294 M | 53.6 M | 65.5 M | 101 M | 133 M | 147 M | 159 M | 84.7 M | 93.5 M | 102 M | 108 M | 119 M | 128 M | 163 M | 178 M | 191 M | 199 M | 201 M | 215 M | 235 M | 246 M | 258 M | 272 M | 287 M | 297 M | 311 M | 324 M | 356 M | 392 M | 422 M | 274 M | 292 M | 194 M | 205 M | 102 M | 113 M | 120 M | 127 M | 26.3 M | 32 M | 32 M | 32 M | 32 M | - | - | - | - |
Cash and Cash Equivalents |
23.6 M | 15.7 M | 19 M | 27.7 M | 14.1 M | 20.1 M | 16 M | 25.8 M | 274 M | 28.1 M | 32 M | 15.4 M | 26.2 M | 25.4 M | 32.1 M | 47 M | 38.1 M | 53.5 M | 24.6 M | 16.9 M | 19.3 M | 21.6 M | 19.7 M | 81.1 M | 23 M | 27.4 M | 22.1 M | 18.5 M | 18.2 M | 23.9 M | 21.9 M | 51.5 M | 49.4 M | 32.1 M | 27.5 M | 20.6 M | 44.7 M | 128 M | 55.6 M | 128 M | 74.4 M | 120 M | 37.4 M | 110 M | 116 M | 115 M | 12 M | 19.9 M | 19.9 M | 19.9 M | 19.9 M | 13.6 M | - | - | - |
Book Value |
136 M | 156 M | 174 M | 193 M | 208 M | 224 M | 240 M | 257 M | 274 M | 27.9 M | 47.8 M | 68.3 M | 105 M | 119 M | 134 M | 73.4 M | 83.2 M | 93.1 M | 101 M | 110 M | 112 M | 149 M | 164 M | 178 M | 189 M | 191 M | 206 M | 222 M | 237 M | 250 M | 263 M | 276 M | 287 M | 300 M | 314 M | 335 M | 370 M | 399 M | 258 M | 275 M | 177 M | 191 M | 89.6 M | 98.5 M | 105 M | 111 M | -2.14 M | 6.69 M | 6.69 M | 6.69 M | 6.69 M | - | - | - | - |
Total Shareholders Equity |
136 M | 156 M | 174 M | 193 M | 208 M | 224 M | 240 M | 257 M | 274 M | 27.9 M | 47.8 M | 68.3 M | 105 M | 119 M | 134 M | 73.4 M | 83.2 M | 93.1 M | 101 M | 110 M | 112 M | 149 M | 164 M | 178 M | 189 M | 191 M | 206 M | 222 M | 237 M | 250 M | 263 M | 276 M | 287 M | 300 M | 314 M | 335 M | 370 M | 399 M | 258 M | 275 M | 177 M | 191 M | 89.6 M | 98.5 M | 105 M | 111 M | -135 M | -101 M | -101 M | -101 M | -101 M | -93.7 M | - | - | - |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Chimerix, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.